Helicobacter pylori: Association with gall bladder disorders in Pakistan

British Journal of Biomedical Science

Volumn 68, Issue 2, 2011, Pages 59-64

  Yakoob, Javed ^a   Khan, M R ^b   Abbas, Z ^a   Jafri, W ^a   Azmi, R ^b   Ahmad, Z ^b   Naeem, S ^b   Lubbad, L ^b  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Bile; Cholecystitis; Cholelithiasis; Gallbladder diseases; Helicobacter pylori

Indexed keywords

BACTERIAL DNA; DNA 16S;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CHOLECYSTITIS; CHOLELITHIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CARCINOMA; GALLBLADDER DISEASE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAKISTAN; POLYP; PRIORITY JOURNAL; RNA SEQUENCE;

HELICOBACTER; HELICOBACTER BILIS; HELICOBACTER HEPATICUS; HELICOBACTER PYLORI;

EID: 79959315538     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2011.11730324     Document Type: Article

References (32)

1. Fox JG. The non-H. pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 2002; 50: 273-83. (Pubitemid 34087945)
2. Fox JG, Dewhirst FE, Tully JG et al. Helicobacter hepaticus sp. nov, a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994; 32: 1238-45. (Pubitemid 24132553)
3. Fox JG, Li X, Yan L et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis. Infect Immun 1996; 64: 1548-58. (Pubitemid 26129814)
4. Fox JG, Lee A. The role of Helicobacter species in newly recognized gastrointestinal tract diseases of animals. Lab Anim Sci 1997; 47: 222-55.
5. Kullberg MC, Ward JM, Gorelick PL et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferondependent mechanism. Infect Immun 1998; 66: 5157-66. (Pubitemid 29044604)
6. Fox JG, Rogers AB, Whary MT et al. Helicobacter bilis-associated hepatitis in outbred mice. Comp Med 2004; 54: 571-7. (Pubitemid 39557452)
7. Ananieva O, Nilsson I, Vorobjova T, Uibo R, Wadstrom T. Immune responses to bile-tolerant Helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors. Clin Diagn Lab Immunol 2002; 9: 1160-4. (Pubitemid 35283275)
8. Kaufman HS, Magnuson TH, Lillemoe KD, Frasca P, Pitt HA. The role of bacteria in gall bladder and common duct stone formation. Ann Surg 1989; 209: 584-91.
9. Hammes F, Boon N, de Villiers J, Verstraete W, Siciliano SD. Strain-specific ureolytic microbial calcium carbonate precipitation. Appl Environ Microbiol 2003; 69: 4901-9. (Pubitemid 36992955)
10. Maurer KJ, Rogers AB, Ge Z et al. Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am J Physiol Gastrointest Liver Physiol 2006; 290: G175-82.
11. Belzer C, Kusters JG, Kuipers EJ, Vanvliet AH. Urease-induced calcium precipitation by Helicobacter species may initiate gallstone formation. Gut 2006; 55: 1678-9. (Pubitemid 44629240)
12. Misra V, Misra SP, Dwivedi M, Shouche Y, Dharne M, Singh PA. Helicobacter pylori in areas of gastric metaplasia in the gall bladder and isolation of H. pylori DNA from gallstones. Pathology 2007; 39: 419-24. (Pubitemid 47221477)
13. Kobayashi T, Harada K, Miwa K, Nakanuma Y. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci 2005; 50: 862-7. (Pubitemid 40684901)
14. Bulajic M, Maisonneuve P, Schneider-Brachert W et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002; 95: 1946-53. (Pubitemid 35222175)
15. Fukuda K, Kuroki T, Tajima Y et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002; 23: 1927-31. (Pubitemid 35355942)
16. Randi G, Franceschi S, La Vecchia C. Gall bladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-602. (Pubitemid 43376420)
17. Zarin M, Ahmed M, Gohar A. Incidence of gallstones in carcinoma gall bladder patients. Pak J Surg 2005; 21: 19-22.
18. Sattar I, Aziz A, Rasul S, Mehmood Z, Khan A. Frequency of infection in cholelithiasis. J Coll Physicians Surg Pak 2007; 17: 48-50.
19. Jafri W, Yakoob J, Abid S, Siddiqui S, Awan S, Nizami SQ. Helicobacter pylori infection in children: population-based agespecific prevalence and risk factors in a developing country. Acta Paediatr 2010; 99: 279-82.
20. Clayton CL, Mobley HLT eds. Helicobacter pylori protocols (Methods in molecular medicine series) 3rd edn. Totowa: Humana Press, 2002: 33.
21. Fox JG, Dewhirst FE, Shen Z et al. Helicobacter species identified in bile and gall bladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114: 755-63. (Pubitemid 28160410)
22. Hamada T, Yokota K, Ayada K et al. Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease. Helicobacter 2009; 14: 545-51.
23. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of H. pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7.
24. Covacci A, Rappuoli R. PCR amplification of gene sequences from Helicobacter pylori strains. In: Helicobacter pylori: techniques for clinical diagnosis and basic research. Philadelphia: Saunders, 1996: 94-109.
25. Marzio L, Angelucci D, Grossi L, Diodoro MG, Di Campli E, Cellini L. Anti-Helicobacter pylori-specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol 1998; 93: 223-6. (Pubitemid 29063972)
26. Goldstein NS. Chronic inactive gastritis and coccoid Helicobacter pylori in patients treated for gastroesophageal reflux disease or with H. pylori eradication therapy. Am J Clin Pathol 2002; 118: 719-26. (Pubitemid 37046316)
27. Chen DF, Hu L, Yi P, Liu WW, Fang DC, Cao H. H. pylori exist in the gall bladder mucosa of patients with chronic cholecystitis. World J Gastroenterol 2007; 13: 1608-11. (Pubitemid 46672673)
28. Caldwell MT, McDermott M, Jazrawi S et al. Helicobacter pylori infection increases following cholecystectomy. Ir J Med Sci 1995; 164: 52-5.
29. Figura N, Cetta F, Angelico M et al. Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation? Dig Dis Sci 1998; 43: 854-62.
30. Tompkins DS, West AP. Campylobacter pylori, acid and bile. J Clin Pathol 1987; 40: 1387.
31. Magnuson TH, Lillemoe KD, Zarkin BA, Pitt HA. Patients with uncomplicated cholelithiasis acidify bile normally. Dig Dis Sci 1992, 37: 1517-22.
32. Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gall bladder. Am J Gastroenterol 2000; 95: 784-7. (Pubitemid 30123920)